Connect with us

Health

Indian maker of syrup linked to death of children in Uzbekistan halts production

Published

on

India’s drug regulator said on Thursday that it had inspected Marion Biotech’s production facility and promised more action based on the probe report after the company’s cough syrup was linked to the death of 19 children in Uzbekistan.

A legal representative of Marion Biotech said the Indian maker of pharmaceuticals and cosmetics regretted the deaths and the company has halted production of the Dok-1 Max syrup, Reuters reported.

The drug regulator reviewed the company’s Noida facility in the Uttar Pradesh state and is in regular touch with its Uzbekistan counterpart, the Indian health ministry said in a statement.

“The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory, Chandigarh for testing,” the ministry said.

Uzbekistan’s health ministry said on Wednesday that at least 18 children in Samarkand city died after consuming the syrup manufactured by the Indian drugmaker.

Another child, a one-year-old, died after being given the syrup for five days, Uzbek news website report.uz said on Thursday, citing the Qashqadaryo regional prosecutor’s office.

Officials in the Samarkand region had initially not reported the deaths to the ministry, the report added, citing Health Minister Bekhzod Musayevand.

Seven employees were dismissed by the Uzbek ministry following a probe into the matter, and “disciplinary measures” were taken against some specialists. The Doc-1 Max tablets and syrups have also been withdrawn from all pharmacies, the Uzbek ministry added in its statement on Wednesday.

The syrup contained a toxic substance, ethylene glycol, and was administered in doses higher than the standard dose for children either by their parents, who mistook it for an anti-cold remedy, or on the advice of pharmacists, the Uzbekistan ministry said.

India’s Ministry of Chemicals and Fertilizers issued an order on Thursday, laying out specifications to regulate the sale of ethylene glycol from the end of March.

The incident follows another similar one in Gambia, where deaths of at least 70 children had been linked to cough and cold syrups manufactured by New Delhi-based Maiden Pharmaceuticals Ltd. The Indian government and also the company, however, have since denied the allegations.

India is known as the ‘pharmacy of the world,’ and has doubled its pharmaceutical exports over the last decade, touching $24.5 billion in the last fiscal year.

Health

Afghan Health Minister hails India visit as new chapter in bilateral ties

Published

on

Afghanistan’s Minister of Public Health, Noor Jalal Jalali, has described his recent visit to India as an important new chapter in strengthening health cooperation between Kabul and New Delhi.

Speaking at a press conference in Kabul on Tuesday, Jalali said the trip focused on expanding bilateral health collaboration and addressing key challenges facing Afghanistan’s healthcare system. He outlined the main objectives of the visit as preventing potential medicine shortages, standardizing traditional medicine, importing high-quality and affordable medicines, building the capacity of health workers through training programs, facilitating medical treatment for Afghan patients in India, and developing professional expertise in traditional medicine.

Jalali said India and relevant institutions made several concrete commitments during the visit. These include the provision of vaccines worth $5 million, a radiotherapy machine for cancer treatment valued at $3 million, five tons of cancer medicines worth $1 million, a CT scan machine valued at $300,000, and support for the construction of a hospital and a specialized thalassemia treatment center valued at $500,000.

According to a statement from the Ministry of Public Health, the visit also resulted in agreements on capacity-building programs for specialists and healthcare workers, the donation of 70,000 medical ampoules by an Afghan investor, plans to establish a research center and an institute of traditional medicine in Kabul, the transfer of high-quality medicines to Afghanistan, meeting market needs, and increased investment in the health sector.

The ministry said these outcomes represent significant progress in enhancing healthcare services and long-term cooperation between Afghanistan and India.

Continue Reading

Health

Afghan health minister hails India’s support, calls medical visas vital for patients

Jalali said India is planning to build a 30-bed hospital in Kabul’s Bagrami district, which is expected to include an oncology center, a trauma unit, and maternal and child healthcare clinics.

Published

on

Afghanistan’s Minister of Public Health, Noor Jalal Jalali, has praised India’s long-standing support for Afghanistan’s healthcare sector, describing Indian medical visas as a “vital humanitarian channel” for Afghan patients.

In an interview with an Indian television network, during his official visit to New Delhi, Jalali said Afghans have long relied on India for medical treatment, noting that the facilitation of medical visas has enabled thousands of patients to access advanced healthcare services in recent years.

He welcomed India’s contributions to Afghanistan’s health infrastructure, highlighting the Indira Gandhi Institute of Child Health in Kabul as one of the country’s most important pediatric hospitals.

India has supported the facility through the establishment of a thalassemia center, a modern diagnostic unit, upgrades to heating systems, and plans to provide a CT scan machine.

Jalali said India is also planning to build a 30-bed hospital in Kabul’s Bagrami district, which is expected to include an oncology center, a trauma unit, and maternal and child healthcare clinics.

He added that India has fitted around 75 Afghan patients with prosthetic limbs under the Jaipur Foot program and donated 20 ambulances.

During talks with India’s Minister of Health and Family Welfare, Jalali called for expanded cooperation in medical equipment, pharmaceutical regulation, training of healthcare workers, and the supply of essential medicines, particularly cancer drugs. He said India has pledged to provide these medicines on an urgent basis.

The Afghan health minister stressed the importance of capacity building, including training Afghan doctors in India and deploying Indian medical teams to Afghanistan.

He also said agreements have been reached to cooperate in traditional medicine, including Ayurveda and Unani practices, with plans to establish a Traditional Medicine Institute and Research Center in Afghanistan.

Jalali noted that Afghanistan has diversified its pharmaceutical import routes to ensure a steady supply of medicines and address concerns over counterfeit and substandard drugs through stronger regulation.

He described Afghanistan–India relations as people-centric and rooted in humanitarian values, expressing hope that cooperation in healthcare, pharmaceuticals, and medical infrastructure will continue to deepen.

Continue Reading

Health

Afghan health officials visit Indian medical institute to expand ties

India has historically been a key partner in Afghanistan’s health and education sectors, providing training, medical support and institutional cooperation.

Published

on

During an official visit to India, a technical delegation from Afghanistan’s Ministry of Public Health visited the Hamdard Institute of Medical Sciences and Research (HIMSR) in New Delhi, as part of efforts to strengthen cooperation in the health sector, particularly in the field of traditional medicine.

Officials and senior professors at HIMSR welcomed the Afghan team and provided detailed briefings on the institution’s academic programmes, research activities and medical services.

Discussions focused on opportunities for closer collaboration in traditional and integrative medicine, an area where Hamdard has long-standing expertise and international recognition.

HIMSR’s leadership expressed readiness to work with Afghan health authorities on joint research initiatives, quality testing and standardisation of traditional medicines through Hamdard’s laboratories, as well as knowledge-sharing programmes. The institution also pledged to offer scholarships and specialised training opportunities for Afghan doctors and medical professionals.

The visit comes as Afghanistan seeks to rebuild and strengthen its public health system amid ongoing economic and humanitarian challenges, with an emphasis on cost-effective and culturally accepted healthcare approaches such as traditional medicine.

India has historically been a key partner in Afghanistan’s health and education sectors, providing training, medical support and institutional cooperation.

Both sides said enhanced collaboration would contribute to improving public health outcomes, standardising traditional medicine practices, and expanding scientific and medical institutions in Afghanistan.

They reaffirmed their commitment to developing the partnership in a sustainable manner, aimed at long-term capacity building and mutual benefit.

Continue Reading
Advertisement
Advertisement
Advertisement
Advertisement

Trending

Copyright © 2025 Ariana News. All rights reserved!